Aflac Incorporated's SEC filings document a supplemental health and life insurer with reportable operations in Japan and the United States. Form 8-K reports furnish quarterly and annual results, supplemental earnings materials, investor presentations and Regulation FD disclosures tied to segment performance, premiums, investment income, dividends and share repurchases.
Proxy and annual-meeting filings cover board elections, executive compensation votes, auditor ratification, shareholder proposals and common-stock voting matters. Other material-event filings describe financing arrangements, including pre-capitalized trust securities and contingent senior-note funding, as well as cybersecurity incident disclosures, operational continuity, customer information risks, governance controls and public-company reporting obligations.
Aflac executive Steven K. Beaver, EVP and CFO of Aflac Japan, reported selling 5,492 shares of Aflac Inc. common stock on 12/12/2025 at a weighted average price of $109.5266 per share, through multiple trades between $109.50 and $109.575. After this transaction, he beneficially owns 38,368 shares of Aflac common stock directly.
Aflac CEO Daniel P. Amos, who also serves as chairman and a director, reported several changes in his Aflac common stock holdings, with the earliest transaction dated 12/12/2025.
Following these transactions, he beneficially owns 742,711 Aflac common shares directly. Indirect holdings include 1,546 shares through his spouse, 3,520 in a spouse IRA, 941,326 through a partnership, and 908,632 as trustee for children. The reported transactions in the table show a price of $0 per share.
Aflac (AFL) insider plans to sell a small block of shares under Rule 144. The notice covers a proposed sale of 5,492 shares of Aflac common stock through broker LPL Financial on the NYSE, with an aggregate market value of $601,099.40 at the time of the filing. The filing notes that 524,113,917 Aflac shares were outstanding, providing context for the relatively small size of this sale. The shares being sold relate to 14,480 shares of vested restricted stock that were acquired from the issuer on 02/11/2024, with cash listed as the form of payment.
Aflac Inc. executive Steven K. Beaver, EVP and CFO of Aflac Japan, reported an employee stock option exercise and related share sale. On 12/05/2025, he exercised an employee stock option to buy 3,452 shares of Aflac common stock at an exercise price of $28.965 per share, then sold 3,452 shares of common stock on the same date at a weighted average price of $109.2601 per share. The option covered 3,452 shares and, after the exercise, the remaining balance of that option position was reported as 0 derivative securities beneficially owned. Following these transactions, Beaver directly owned 43,860 shares of Aflac common stock.
Aflac Inc. senior executive Audrey B. Tillman, Sr. Executive Vice President, reported a Form 4 insider transaction involving Aflac common stock. On 12/05/2025, she disposed of 1,038 shares of common stock in a transaction coded “G,” indicating a gift, at a reported price of $0 per share. Following this transaction, she beneficially owns 229,650 Aflac shares directly, plus 17,993 shares held through a 401(k) plan, and 9 shares reported as held by her children.
Aflac Incorporated insider plans to sell common stock under Rule 144. The notice covers the proposed sale of 3,452 shares of Aflac common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $377,165.88. These shares relate to an option originally granted on February 9, 2016 and paid for in cash on December 5, 2025. Aflac had 524,113,917 shares outstanding, providing context for the size of this planned sale.
Aflac Inc. officer reports stock option exercise and share sale
A senior executive vice president of Aflac Inc. (AFL) reported a same-day stock option exercise and sale. On 11/18/2025, the officer exercised an employee stock option to acquire 15,862 shares of Aflac common stock at an exercise price of $28.965 per share, then sold 15,862 shares of common stock at a price of $112 per share. After these transactions, the officer directly owned 230,688 shares of Aflac common stock, with additional indirect holdings of 17,899 shares through a 401(k) plan and 9 shares held by children.
Aflac Inc. (AFL) director Joseph L. Moskowitz reported an insider transaction involving company stock. On 11/17/2025, he exercised a director stock option for 2,000 shares of common stock at an exercise price of $44.59 per share, increasing his direct share holdings.
On the same date, he reported a sale of 786 shares of Aflac common stock at a price of $113.745 per share. After these transactions, he directly beneficially owned 24,829 shares of Aflac common stock and held 20,303 derivative securities (stock options) directly.
Aflac Incorporated reported an insider transaction by its Sr. Executive Vice President, Audrey B. Tillman. On 11/14/2025, she exercised an employee stock option to buy 3,452 shares of common stock at $28.965 per share and on the same date sold 3,452 shares at $115.10 per share. After these transactions, she directly holds 230,688 shares of Aflac common stock, plus 17,899 shares through a 401(k) plan and 9 shares held by her children. Following the option exercise, she continues to hold 15,862 employee stock options.
Aflac Incorporated (AFL) shareholder filed a Form 144 notice to sell 15,862 shares of common stock. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,776,544.00 and 524,113,917 common shares outstanding noted for context.
The shares to be sold were acquired on 11/18/2025 through the exercise of an option originally granted on 02/09/2016, paid for in cash. The filing also reports that the same seller disposed of 3,452 common shares on 11/14/2025 for gross proceeds of $397,325.20 during the prior three months.